DXBR.F Stock Overview
Develops, markets, and sells cannabis products in the United States, Canada, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
BellRock Brands Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.026 |
52 Week Low | US$0.000001 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | 0% |
33 Year Change | -100.00% |
5 Year Change | n/a |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
DXBR.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -1.4% | 0.6% |
1Y | 0% | 22.2% | 32.1% |
Return vs Industry: DXBR.F underperformed the US Pharmaceuticals industry which returned 22.3% over the past year.
Return vs Market: DXBR.F underperformed the US Market which returned 31.9% over the past year.
Price Volatility
DXBR.F volatility | |
---|---|
DXBR.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: DXBR.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DXBR.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Brian Jansen | www.bellrockbrands.com |
BellRock Brands Inc. develops, markets, and sells cannabis products in the United States, Canada, and internationally. It offers cannabis infused adult-use topicals, confections, edibles, beverages, and concentrates, as well as transdermal patches, tinctures, capsules, lotions, creams, other topicals, vapes, and cosmetic serums. The company also provides branded hemp-infused products for humans and pets.
BellRock Brands Inc. Fundamentals Summary
DXBR.F fundamental statistics | |
---|---|
Market cap | US$1.09k |
Earnings (TTM) | -US$31.44m |
Revenue (TTM) | US$33.87m |
0.0x
P/S Ratio0.0x
P/E RatioIs DXBR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DXBR.F income statement (TTM) | |
---|---|
Revenue | US$33.87m |
Cost of Revenue | US$23.34m |
Gross Profit | US$10.52m |
Other Expenses | US$41.97m |
Earnings | -US$31.44m |
Last Reported Earnings
Dec 31, 2019
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did DXBR.F perform over the long term?
See historical performance and comparison